JAKARTA (Xinhua): The vaccine for the novel coronavirus disease (Covid-19) being developed by Indonesia has successfully passed eight phases of trials and will undergo seven other examinations, the Covid-19 Task Force said on Tuesday (July 7).
The vaccine is jointly developed by Eijkman Institute for Bio-molecular Biology of Indonesia, the country's PT Bio Farma and PT Kalbe Farma, as well as a South Korean firm, said Reisa Broto Asmoro, a member of the task force, adding that the process will take a long time.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
